BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1320798)

  • 1. Identification of candidate sequences that determine virulence in Coxsackievirus B4.
    Ramsingh A; Araki H; Bryant S; Hixson A
    Virus Res; 1992 May; 23(3):281-92. PubMed ID: 1320798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a single amino acid residue in the capsid protein VP1 of coxsackievirus B4 that determines the virulent phenotype.
    Caggana M; Chan P; Ramsingh A
    J Virol; 1993 Aug; 67(8):4797-803. PubMed ID: 8392614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular epidemiology of coxsackievirus B4 and disclosure of the correct VP1/2A(pro) cleavage site: evidence for high genomic diversity and long-term endemicity of distinct genotypes.
    Mulders MN; Salminen M; Kalkkinen N; Hovi T
    J Gen Virol; 2000 Mar; 81(Pt 3):803-12. PubMed ID: 10675418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A single amino acid substitution in the capsid protein VP1 of coxsackievirus B3 (CVB3) alters plaque phenotype in Vero cells but not cardiovirulence in a mouse model.
    Zhang H; Blake NW; Ouyang X; Pandolfino YA; Morgan-Capner P; Archard LC
    Arch Virol; 1995; 140(5):959-66. PubMed ID: 7605207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A point mutation in VP1 of coxsackievirus B4 alters antigenicity.
    Halim S; Ramsingh AI
    Virology; 2000 Mar; 269(1):86-94. PubMed ID: 10725201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A point mutation in the VP4 coding sequence of coxsackievirus B4 influences virulence.
    Ramsingh AI; Collins DN
    J Virol; 1995 Nov; 69(11):7278-81. PubMed ID: 7474153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intratypic genome variability of echovirus type 30 in part of the VP4/VP2 coding region.
    Gjøen K; Bruu AL; Orstavik I
    Arch Virol; 1996; 141(5):901-8. PubMed ID: 8678835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyoma virus DNA: complete nucleotide sequence of the gene which codes for polyoma virus capsid protein VP1 and overlaps the VP2/VP3 genes.
    Soeda E; Arrand JR; Griffin BE
    J Virol; 1980 Feb; 33(2):619-30. PubMed ID: 6251237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in the poliovirus P1 capsid precursor at arginine residues VP4-ARG34, VP3-ARG223, and VP1-ARG129 affect virus assembly and encapsidation of genomic RNA.
    Ansardi DC; Luo M; Morrow CD
    Virology; 1994 Feb; 199(1):20-34. PubMed ID: 8116243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular characterization of mouse-virulent poliovirus type 1 Mahoney mutants: involvement of residues of polypeptides VP1 and VP2 located on the inner surface of the capsid protein shell.
    Couderc T; Hogle J; Le Blay H; Horaud F; Blondel B
    J Virol; 1993 Jul; 67(7):3808-17. PubMed ID: 8389907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The amino acid sequence of the outer coat protein VP2 of neutralizing monoclonal antibody-resistant, virulent and attenuated bluetongue viruses.
    Gould AR; Eaton BT
    Virus Res; 1990 Nov; 17(3):161-72. PubMed ID: 1706548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virulence of swine vesicular disease virus is determined at two amino acids in capsid protein VP1 and 2A protease.
    Kanno T; Mackay D; Wilsden G; Kitching P
    Virus Res; 2001 Nov; 80(1-2):101-7. PubMed ID: 11597755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complete nucleotide sequence of a strain of coxsackie B4 virus of human origin that induces diabetes in mice and its comparison with nondiabetogenic coxsackie B4 JBV strain.
    Kang Y; Chatterjee NK; Nodwell MJ; Yoon JW
    J Med Virol; 1994 Dec; 44(4):353-61. PubMed ID: 7897366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attenuating mutations in coxsackievirus B3 map to a conformational epitope that comprises the puff region of VP2 and the knob of VP3.
    Stadnick E; Dan M; Sadeghi A; Chantler JK
    J Virol; 2004 Dec; 78(24):13987-4002. PubMed ID: 15564506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of sequence changes responsible for the attenuation of highly virulent infectious bursal disease virus.
    Yamaguchi T; Ogawa M; Inoshima Y; Miyoshi M; Fukushi H; Hirai K
    Virology; 1996 Sep; 223(1):219-23. PubMed ID: 8806555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural recombination event within the capsid genomic region leading to a chimeric strain of human enterovirus B.
    Bouslama L; Nasri D; Chollet L; Belguith K; Bourlet T; Aouni M; Pozzetto B; Pillet S
    J Virol; 2007 Sep; 81(17):8944-52. PubMed ID: 17537864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coxsackievirus B3: primary structure of the 5' non-coding and capsid protein-coding regions of the genome.
    Tracy S; Liu HL; Chapman NM
    Virus Res; 1985 Oct; 3(3):263-70. PubMed ID: 3000101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of the sequences of segment A of four infectious bursal disease virus strains and identification of a variable region in VP2.
    Bayliss CD; Spies U; Shaw K; Peters RW; Papageorgiou A; Müller H; Boursnell ME
    J Gen Virol; 1990 Jun; 71 ( Pt 6)():1303-12. PubMed ID: 2161902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic mapping of the determinants of plaque morphology of coxsackievirus B4.
    Ramsingh AI; Caggana M; Ronstrom S
    Arch Virol; 1995; 140(12):2215-26. PubMed ID: 8572942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The major echovirus group is genetically coherent and related to coxsackie B viruses.
    Huttunen P; Santti J; Pulli T; Hyypiä T
    J Gen Virol; 1996 Apr; 77 ( Pt 4)():715-25. PubMed ID: 8627260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.